Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
 | ALVOTECH | 3 | - | +5,64 % | |
 | FESTI | 1 | 4 | - | |
| KVIKA BANKI | 1 | - | - | |
| AMAROQ | - | 5 | +0,84 % | ||
| JBT MAREL | - | 2 | +0,99 % | ||
| ARION BANK | - | 1 | 0,00 % | ||
| ICELANDAIR GROUP HF | - | - | - | |
| HAGAR | - | - | - | |
| SKAGI | - | - | - | |
| BRIM | - | - | - |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Kvika banki hf.: Transaction in relation to a share buy-back programme | 3 | GlobeNewswire (USA) | ||
| Mo | Alvotech - 6-K, Report of foreign issuer | 6 | SEC Filings | ||
| Mo | Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio to subcutaneous presentations | 269 | GlobeNewswire (Europe) | REYKJAVIK, Iceland, August 31, 2026 - Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide... ► Artikel lesen | |
| Mo | Alvotech S.A.: Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio to subcutaneous presentations | 301 | GlobeNewswire (Europe) | REYKJAVIK, Iceland, August 31, 2026 - Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide... ► Artikel lesen | |
| Mo | Festi hf.: Transactions in relation to a share repurchase programme - week 35 | 4 | GlobeNewswire (USA) | ||
| 25.08. | H.C. Wainwright bestätigt Oculis-Rating nach Beginn zulassungsrelevanter Studie | 2 | Investing.com Deutsch | ||
| 25.08. | H.C. Wainwright reiterates Oculis stock rating on trial start | 2 | Investing.com | ||
| 25.08. | KeyBanc initiates JBT Marel stock coverage with overweight rating | 2 | Investing.com |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.